Daré Bioscience (DARE) Revenue & Revenue Breakdown
Daré Bioscience Revenue Highlights
Latest Revenue (Y)
$9.78M
Latest Revenue (Q)
$-63.65K
Main Segment (Y)
License And Collaboration Revenues
Daré Bioscience Revenue by Period
Daré Bioscience Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $9.78M | 248.45% |
2023-12-31 | $2.81M | -71.92% |
2022-12-31 | $10.00M | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | -100.00% |
2016-12-31 | $766.00K | 100.00% |
2015-12-31 | - | -100.00% |
2014-12-31 | $80.00K | 1233.33% |
2013-12-31 | $6.00K | -99.04% |
2012-12-31 | $625.00K | 104.92% |
2011-12-31 | $305.00K | - |
Daré Bioscience generated $9.78M in revenue during NA 2024, up 248.45% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Daré Bioscience Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-12-31 | $-63.65K | -252.66% |
2024-09-30 | $41.69K | 85.81% |
2024-06-30 | $22.44K | 141.22% |
2024-03-31 | $9.30K | -99.49% |
2023-12-31 | $1.81M | 80.79% |
2023-09-30 | $1.00M | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $10.00B | 100.00% |
2022-09-30 | - | -100.00% |
2022-06-30 | $10.00M | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $-1.83M | 100.00% |
2017-09-30 | - | -100.00% |
2017-06-30 | $642.00K | -46.14% |
2017-03-31 | $1.19M | 55.61% |
2016-12-31 | $766.00K | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | -100.00% |
2014-06-30 | $33.00K | -29.79% |
2014-03-31 | $47.00K | 683.33% |
2013-12-31 | $6.00K | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | - |
Daré Bioscience generated $-63.65K in revenue during Q4 2024, up -252.66% compared to the previous quarter, and up -6.36% compared to the same period a year ago.
Daré Bioscience Revenue Breakdown
Daré Bioscience Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 | Dec 22 | Dec 20 |
---|---|---|---|
License And Collaboration Revenues | $11.00M | $10.00M | - |
Royalty Revenue | $18.00K | - | - |
Grant | - | - | $2.50M |
Daré Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 24: License And Collaboration Revenues (99.84%), and Royalty Revenue (0.16%).
Quarterly Revenue by Product
Product/Service | Mar 25 | Sep 24 | Sep 23 | Sep 22 | Jun 22 |
---|---|---|---|---|---|
License And Collaboration Revenue | $12.80M | $12.80M | - | - | - |
License And Collaboration Revenues | - | - | $11.00M | $10.00M | $10.00M |
Daré Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: License And Collaboration Revenue (100.00%).
Daré Bioscience Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Sep 22 | Jun 22 |
---|---|---|
License And Collaboration Revenues | $10.00M | $10.00M |
Daré Bioscience's latest quarterly revenue breakdown by geography, as of Sep 22: License And Collaboration Revenues (100.00%).
Daré Bioscience Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CNTB | Connect Biopharma | $26.03M | - |
DARE | Daré Bioscience | $9.78M | $-63.65K |
XBIO | Xenetic Biosciences | $2.50M | $648.82K |
QTTB | Q32 Bio | $1.16M | - |
VTVT | vTv Therapeutics | $1.02M | - |
EYEN | Eyenovia | $57.34K | $28.09K |
CRVO | CervoMed | - | - |
COCP | Cocrystal Pharma | - | - |
NDRA | ENDRA Life Sciences | - | - |
ACHV | Achieve Life Sciences | - | - |